Table 1.
Human immunodeficiency virus, hepatitis B virus and hepatitis C virus and their co-infection status among prisoners from Middle East and North Africa countries between 2005 and 2015
| Country | n | Mean age/age | HIV (%) | HBV (%) | HCV (%) | HIV-HBV co-infection (%) | HIV-HCV co-infection (%) | Triple infection (%) | Ref. |
| Egypt | 500 | 41.0 | 0.0 | 9.8 | 15.8 | 0.0 | 0.0 | 0.0 | [14] |
| Iran | 160 | 16.6 | 0.6 | 0.6 | NS | 0.0 | NS | NS | [15] |
| 392a | 35.9 | 17.0 | 4.5 | 80.5 | 0.8 | 14.5 | 0.8 | [16] | |
| 358b | 34.7 | 0.0 | 6.1 | 8.1 | 0.0 | 0.0 | 0.0 | [17] | |
| 163 | 34.5 | 0.0 | 7.4 | 7.4 | 0.0 | 0.0 | 0.0 | [18] | |
| 249a | 35.4 | 15.1 | 4.7 | 64.8 | 1.1 | 14.3 | 1.1 | [19] | |
| 150a | 31.4 | 42.5 | 18.9 | 75.9 | NR | NR | NR | [20] | |
| Lebanon | 580 | 31.7 | 0.2 | 2.4 | 3.4 | 0.0 | 0.0 | 0.0 | [21] |
| Libya | 6371 | > 16 | 18.2 | 6.9 | 23.7 | NR | NR | 1.5 | [22] |
a
Among prisoners who inject drugs;
b
Drug-related convictions; n: Sample size; NR: Not reported; NS: Not studied. All numbers were rounded to the nearest 1. HIV: Human immunodeficiency virus; HBV: Hepatitis B virus; HCV: Hepatitis C virus.